Information about Morliplas
My details
*
*
*

Morliplas (SPRL)

BE

0560.822.326

Company information

Status
Active

Enterprise number

BE0560.822.326

VAT liability
Yes
Established
27-08-2014
Last balance sheet year
2025
Company size
Small 0 FTE
Legal form
Société privée à responsabilité limitée (SPRL)
Principal activity
Retail sale of other new goods
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Morliplas

2025 2024 2023 2022
Income statement
Profit/Loss € 67,922 -9% € 74,672 43% € 52,068 -20% € 65,347
Gross margin € 146,601 -9% € 160,585 25% € 128,578 -10% € 142,775
Balance sheet
Balance sheet total € 1,080,723 -5% € 1,140,052 6% € 1,078,073 6% € 1,019,361
Equity € 390,182 21% € 322,260 30% € 247,588 27% € 195,520
Debts € 690,541 -16% € 817,792 -2% € 830,485 1% € 823,841

Publications from Morliplas

Date Publication
02-09-2014 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Morliplas?
The VAT number of Morliplas is BE 0560.822.326.
Wat is the PEPPOL ID of Morliplas?
The PEPPOL ID of Morliplas is 0208:0560822326. Log in or start a free trial to see the full overview.
When was Morliplas founded?
Morliplas was founded on 27-08-2014.
What is the address of Morliplas?
The current registered office of Morliplas is located at Nedermolenstraat 122, 9310 Aalst.
When was the last time Morliplas filed their annual financial statements?
The most recent financial statements of Morliplas were filed on 27-03-2026.
How many employees does Morliplas have?
There are currently no employees working at Morliplas or no workforce information is available.
What is the annual turnover of Morliplas?
At the time of its most recent financial statements, Morliplas did not publish any turnover figures. Morliplas reported a gross margin of €146,601.17.

Sources